Prognostic Value of PKM2 Expression in de novo Metastatic Colorectal Cancer Patients

Volume 26, Issue 9, September 2025, Pages 3485-3493

Ahmed Refaat; Nada Mohammad Hussien; Rabab Mohamed Mumdouh Farghaly; Marwa T. Hussien; Abeer Ibrahim

• View Article
• PDF 862.71 K

Revolutionizing HER2-Positive Breast Cancer Treatment: Insights from the 47th San Antonio Breast Cancer Symposium on Trastuzumab Deruxtecan

Volume 26, Issue 8, August 2025, Pages 2695-2697

Alireza Negahi; Hossein Negahban; Soheila Sayyad; Mehdi Khosravi-Mashizi; Abolhasan Alijanpour; Hossein Neamatzadeh

• View Article
• PDF 301.07 K

Efficacy of Neoadjuvant Single or Dual Anti-HER-2 Therapy Combined with Chemotherapy in Patients with HER-2-Positive Breast Cancer: A Single-Center Retrospective Study

Volume 22, Issue 5, May 2021, Pages 1467-1475

Qian He; Jia-Yi Li; Qing-Lan Ren

• View Article
• PDF 520.63 K

Prognostic Value of Two Polymorphisms, rs1045642 and rs1128503, in ABCB1 Following Taxane-based Chemotherapy: A Meta-Analysis

Volume 22, Issue 1, January 2021, Pages 3-10

Quanyao Chen; Wanlong Lin; Jianhui Yang; Min Lin; Xiuxian Lin; Yiyin Weng; Yao Chen

• View Article
• PDF 591.93 K

Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes

Volume 19, Issue 5, May 2018, Pages 1295-1302

Putsarat Insin; Nisa Prueksaritanond

• View Article
• PDF 520.34 K

Verification of the Correlation between Progression-free Survival and Overall Survival Considering Magnitudes of Survival Postprogression in the Treatment of Four Types of Cancer

Volume 16, Issue 3, March 2015, Pages 1001-1006

• View Article
• PDF 562.37 K

Clinical Study of Nimotuzumab Combined with Chemotherapy in the Treatment of Late Stage Gastric Cancer

Volume 15, Issue 23, December 2014, Pages 10273-10276

• View Article
• PDF 523.08 K

Clinical and Pathologic Features of Patients with Rare Ovarian Tumors: Multi-Center Review of 167 Patients by the Anatolian Society of Medical Oncology

Volume 14, Issue 11, November 2013, Pages 6493-6499

• View Article
• PDF 606.67 K

CXCR4 Expression in Patients with High-risk Locally Advanced Renal Cell Carcinoma Can Independently Predict Increased Risk of Disease Progression and Poor Overall Survival

Volume 12, Issue 12, December 2011, Pages 3313-3318

• View Article
• PDF 467.81 K